NCT00286949View on ClinicalTrials.gov

Treatment of Executive Dysfunction in Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 6, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Parkinson's Disease
Interventions
DRUG

Atomoxetine

Open Label uncontrolled active Drug intervention

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00286949 - Treatment of Executive Dysfunction in Parkinson's Disease | Biotech Hunter | Biotech Hunter